258 related articles for article (PubMed ID: 21767643)
1. Incorporation of indomethacin nanoparticles into 3-D ordered macroporous silica for enhanced dissolution and reduced gastric irritancy.
Hu Y; Zhi Z; Wang T; Jiang T; Wang S
Eur J Pharm Biopharm; 2011 Nov; 79(3):544-51. PubMed ID: 21767643
[TBL] [Abstract][Full Text] [Related]
2. Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica.
Wang Y; Zhao Q; Hu Y; Sun L; Bai L; Jiang T; Wang S
Int J Nanomedicine; 2013; 8():4015-31. PubMed ID: 24174875
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods.
Limnell T; Santos HA; Mäkilä E; Heikkilä T; Salonen J; Murzin DY; Kumar N; Laaksonen T; Peltonen L; Hirvonen J
J Pharm Sci; 2011 Aug; 100(8):3294-3306. PubMed ID: 21520084
[TBL] [Abstract][Full Text] [Related]
4. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles.
Tahvanainen M; Rotko T; Mäkilä E; Santos HA; Neves D; Laaksonen T; Kallonen A; Hämäläinen K; Peura M; Serimaa R; Salonen J; Hirvonen J; Peltonen L
Int J Pharm; 2012 Jan; 422(1-2):125-31. PubMed ID: 22063301
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical stability of high indomethacin payload ordered mesoporous silica MCM-41 and SBA-15 microparticles.
Limnell T; Heikkilä T; Santos HA; Sistonen S; Hellstén S; Laaksonen T; Peltonen L; Kumar N; Murzin DY; Louhi-Kultanen M; Salonen J; Hirvonen J; Lehto VP
Int J Pharm; 2011 Sep; 416(1):242-51. PubMed ID: 21763766
[TBL] [Abstract][Full Text] [Related]
6. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs.
Simovic S; Heard P; Hui H; Song Y; Peddie F; Davey AK; Lewis A; Rades T; Prestidge CA
Mol Pharm; 2009; 6(3):861-72. PubMed ID: 19358600
[TBL] [Abstract][Full Text] [Related]
7. Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug.
Hu Y; Wang J; Zhi Z; Jiang T; Wang S
J Colloid Interface Sci; 2011 Nov; 363(1):410-7. PubMed ID: 21820127
[TBL] [Abstract][Full Text] [Related]
8. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Kumar D; Sailaja Chirravuri SV; Shastri NR
Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
[TBL] [Abstract][Full Text] [Related]
9. Elaboration and structural analysis of aquasomes loaded with indomethacin.
Rojas-Oviedo I; Salazar-López RA; Reyes-Gasga J; Quirino-Barreda CT
Eur J Pharm Sci; 2007 Nov; 32(3):223-30. PubMed ID: 17905573
[TBL] [Abstract][Full Text] [Related]
10. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
11. Study on formulation variables of methotrexate loaded mesoporous MCM-41 nanoparticles for dissolution enhancement.
Vadia N; Rajput S
Eur J Pharm Sci; 2012 Jan; 45(1-2):8-18. PubMed ID: 22067974
[TBL] [Abstract][Full Text] [Related]
12. New solid lipid microparticles for controlled ibuprofen release: formulation and characterization study.
Perge L; Robitzer M; Guillemot C; Devoisselle JM; Quignard F; Legrand P
Int J Pharm; 2012 Jan; 422(1-2):59-67. PubMed ID: 22027394
[TBL] [Abstract][Full Text] [Related]
13. Effects of particle morphology, pore size and surface coating of mesoporous silica on Naproxen dissolution rate enhancement.
Guo Z; Liu XM; Ma L; Li J; Zhang H; Gao YP; Yuan Y
Colloids Surf B Biointerfaces; 2013 Jan; 101():228-35. PubMed ID: 23010024
[TBL] [Abstract][Full Text] [Related]
14. Indomethacin-loaded polymeric nanocarriers based on amphiphilic polyphosphazenes with poly (N-isopropylacrylamide) and ethyl tryptophan as side groups: Preparation, in vitro and in vivo evaluation.
Zhang JX; Li XJ; Qiu LY; Li XH; Yan MQ; Yi Jin ; Zhu KJ
J Control Release; 2006 Dec; 116(3):322-9. PubMed ID: 17109985
[TBL] [Abstract][Full Text] [Related]
15. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate.
Ambrogi V; Perioli L; Marmottini F; Giovagnoli S; Esposito M; Rossi C
Eur J Pharm Sci; 2007 Nov; 32(3):216-22. PubMed ID: 17826966
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel mesoporous silica nanoparticles for loading and release of ibuprofen.
Zhang H; Li Z; Xu P; Wu R; Wang L; Xiang Y; Jiao Z
J Control Release; 2011 Nov; 152 Suppl 1():e38-9. PubMed ID: 22195911
[No Abstract] [Full Text] [Related]
17. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
[TBL] [Abstract][Full Text] [Related]
18. The On-Off chiral mesoporous silica nanoparticles for delivering achiral drug in chiral environment.
Fan N; Liu R; Ma P; Wang X; Li C; Li J
Colloids Surf B Biointerfaces; 2019 Apr; 176():122-129. PubMed ID: 30597409
[TBL] [Abstract][Full Text] [Related]
19. Inclusion of celecoxib into fibrous ordered mesoporous carbon for enhanced oral bioavailability and reduced gastric irritancy.
Zhao P; Jiang H; Jiang T; Zhi Z; Wu C; Sun C; Zhang J; Wang S
Eur J Pharm Sci; 2012 Apr; 45(5):639-47. PubMed ID: 22251657
[TBL] [Abstract][Full Text] [Related]
20. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole.
Kinnari P; Mäkilä E; Heikkilä T; Salonen J; Hirvonen J; Santos HA
Int J Pharm; 2011 Jul; 414(1-2):148-56. PubMed ID: 21601623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
